Rate My Professor Anissa Widjaja

Her research focuses on the molecular mechanisms of organ injury, tissue regeneration, fibro-inflammatory diseases, ageing, and related conditions including diabetes, liver disease, kidney disease, and cardiovascular fibrosis. Key contributions include co-authorship on the 2017 Nature paper identifying IL-11 as a crucial determinant of cardiovascular fibrosis, the 2019 Science Translational Medicine paper on interleukin-11 as a therapeutic target in idiopathic pulmonary fibrosis, and additional publications in journals such as Nature Communications and Gastroenterology addressing IL-11 signalling in models of kidney disease, liver injury, and nonalcoholic steatohepatitis. At Duke-NUS, she leads her own laboratory, serves as Faculty-Industry Liaison, and contributes to strategic partnerships and industry alliances. She has received grant awards and team recognition, including involvement in the SingHealth Duke-NUS Research Team Award for work on IL-11 inhibition.